Skip to main content
Loading
Cart
Facebook
Twitter
LinkedIn
Toggle search
Toggle navigation
Keyword Search
Sign In
Education
Toggle
OSMA Learning Portal
CME: Proper Prescribing Live Webinar
On-Demand CME Courses
Upcoming Events
Get CME Credit
Advocacy
Toggle
Issues Impacting Oklahoma Doctors
Medicine Day
Doctor of the Day
No Surprises Act
Patient Safety
OMPAC
2024 Annual Meeting
Join/Renew OSMA
Member Benefits
Toggle
Advocacy
Continuing Medical Education
Marijuana Resource Center
COVID-19 Resource Center
Meinders Professional Programs
Physician Wellness Programs
Member Services
Oklahoma Health Professionals Program (OHPP)
OSMA Journal
About OSMA
Toggle
Board of Trustees
Councils and Committees
OSMA Staff
OSMA Foundation
Physicians' Campaign for a Healthier Oklahoma (PCHO)
Oklahoma AMA Delegation
County Medical Societies
OSMA Bylaws
OSMA Policy Compendium
Vision & Mission
Find A Physician
Supreme Court Upholds Licensure Board’s Authority
On March 27, 2023, the Oklahoma Supreme Court upheld the authority of the State Board of Medical Licensure and Supervision and State Board of Pharmacy to regulate the authority of a physician assistant to prescribe Schedule II narcotics.
According to the Court
ruling
and
concurring statement
, the opinion stated:
“Specifically, Petitioner (Oklahoma Academy of Physician Assistants, Inc.) has failed to show (emphasis added) that, prior to the November 3, 2022, directive issued by the Oklahoma State Board of Pharmacy and the administrative rules adopted by the Oklahoma State Board of Medical Licensure on November 17, 2022, physician assistants possessed statutory authority to prescribe Schedule II narcotics for off-site administration.”
OSMA along with the Oklahoma Osteopathic Association (OOA), Oklahoma Dental Association and the Academy of Family Physicians filed an Amici Curiae (“friend of the court”) Brief in support of the Board’s authority.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##